Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature
A review of studies found no evidence that radioactive iodine treatment after surgery benefits low-risk differentiated thyroid cancer patients. The results for intermediate-risk patients are mixed, with some studies suggesting a benefit and others showing no effect. This highlights the need for better quality evidence, such as from randomized controlled trials, to guide decisions about radioactive iodine treatment in these patients.